Free Trial

Molina Healthcare (NYSE:MOH) Sets New 12-Month Low - Time to Sell?

Molina Healthcare logo with Medical background

Molina Healthcare, Inc (NYSE:MOH - Get Free Report)'s stock price reached a new 52-week low on Monday . The company traded as low as $177.16 and last traded at $178.44, with a volume of 979429 shares traded. The stock had previously closed at $182.98.

Analyst Upgrades and Downgrades

Several research analysts recently commented on MOH shares. Baird R W lowered shares of Molina Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Robert W. Baird reaffirmed a "neutral" rating and issued a $375.00 price objective (up previously from $331.00) on shares of Molina Healthcare in a report on Tuesday, April 15th. Wall Street Zen cut Molina Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, June 29th. Morgan Stanley downgraded shares of Molina Healthcare from an "overweight" rating to an "equal weight" rating and reduced their price objective for the stock from $364.00 to $266.00 in a report on Thursday, July 10th. Finally, Sanford C. Bernstein started coverage on Molina Healthcare in a report on Tuesday, April 22nd. They set an "outperform" rating and a $414.00 price objective on the stock. Eleven analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $347.57.

View Our Latest Research Report on MOH

Molina Healthcare Stock Performance

The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.63 and a current ratio of 1.63. The business has a 50 day moving average price of $281.73 and a two-hundred day moving average price of $300.46. The company has a market cap of $9.55 billion, a P/E ratio of 8.51, a price-to-earnings-growth ratio of 0.81 and a beta of 0.55.

Molina Healthcare (NYSE:MOH - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, topping analysts' consensus estimates of $5.96 by $0.12. Molina Healthcare had a return on equity of 28.38% and a net margin of 2.81%. The firm had revenue of $11.15 billion for the quarter, compared to the consensus estimate of $10.86 billion. During the same quarter in the prior year, the business earned $5.73 EPS. The business's revenue for the quarter was up 12.2% on a year-over-year basis. On average, sell-side analysts anticipate that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.

Insider Buying and Selling at Molina Healthcare

In related news, CEO Joseph M. Zubretsky sold 87,500 shares of the firm's stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total value of $28,005,250.00. Following the transaction, the chief executive officer directly owned 257,715 shares of the company's stock, valued at approximately $82,484,262.90. This trade represents a 25.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Richard M. Schapiro sold 669 shares of the firm's stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total value of $214,414.50. Following the completion of the transaction, the director directly owned 11,244 shares in the company, valued at approximately $3,603,702. This represents a 5.62% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.26% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Amalgamated Bank grew its position in Molina Healthcare by 0.3% in the first quarter. Amalgamated Bank now owns 11,580 shares of the company's stock worth $3,814,000 after acquiring an additional 33 shares in the last quarter. Deseret Mutual Benefit Administrators grew its position in Molina Healthcare by 60.7% in the first quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock worth $30,000 after acquiring an additional 34 shares in the last quarter. JLB & Associates Inc. grew its position in Molina Healthcare by 0.3% in the first quarter. JLB & Associates Inc. now owns 10,626 shares of the company's stock worth $3,500,000 after acquiring an additional 36 shares in the last quarter. PenderFund Capital Management Ltd. grew its position in Molina Healthcare by 0.4% in the first quarter. PenderFund Capital Management Ltd. now owns 10,071 shares of the company's stock worth $3,317,000 after acquiring an additional 40 shares in the last quarter. Finally, Angeles Investment Advisors LLC grew its position in Molina Healthcare by 5.4% in the fourth quarter. Angeles Investment Advisors LLC now owns 838 shares of the company's stock worth $244,000 after acquiring an additional 43 shares in the last quarter. Hedge funds and other institutional investors own 98.50% of the company's stock.

About Molina Healthcare

(Get Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines